NCT03203837View on ClinicalTrials.gov

Biomarker Analyses in Hepatocellular Carcinoma (HCC) Patients Treated With TheraSphere®

TerminatedOBSERVATIONAL
Enrollment

4

Participants

Timeline

Start Date

July 5, 2017

Primary Completion Date

January 6, 2020

Study Completion Date

January 6, 2020

Conditions
Hepatocellular Carcinoma
Interventions
OTHER

Plasma collection

We will be collecting plasma at 7 different timepoints in hepatocellular carcinoma patients that are treated with radioembolization.

Trial Locations (1)

60611

Northwestern University, Chicago

Sponsors

Collaborators (1)

BTG International Inc.
All Listed Sponsors
collaborator

BTG International Inc.

OTHER

lead

Northwestern University

OTHER